The NCLT has approved the restructuring of India Glycols into three focused entities: chemicals, spirits, and nutraceuticals. Shareholders will receive new shares under the split, which analysts expect to unlock value. The company recently reported a 19.4% increase in revenue to ₹2,988.44 crore for the first quarter of FY27, while clarifying that recent stock volatility was market-driven.
The National Company Law Tribunal (NCLT) has officially approved the plan to split India Glycols Limited into three separate, independent companies. This restructuring, sanctioned on July 17, 2026, aims to make each part of the business—specialty chemicals, spirits and biofuels, and nutraceuticals and active pharmaceutical ingredients (APIs)—more focused and efficient. By operating as distinct entities, the company intends to allow each business unit to pursue its own growth strategy without being tied to the performance of the others.
New Business Structure and Shareholder Allotment
Under the approved scheme, the business will be divided into three entities: India Glycols (for specialty chemicals), IGL Spirits (covering spirits and biofuels), and Ennature Bio Pharma (focusing on nutraceuticals and APIs). For shareholders, the split involves a specific allocation ratio. Investors will receive one share of IGL Spirits for every one share of India Glycols held. Additionally, shareholders will receive one share of Ennature Bio Pharma for every three shares held in the original company. The appointed date for the restructuring was April 1, 2026.
Financial Performance and Analyst Outlook
The company recently reported strong financial results for the first quarter of the 2027 fiscal year. Consolidated revenue rose by 19.4% year-on-year to ₹2,988.44 crore, while net profit grew by 32.2% to ₹96.83 crore. Following these results and the demerger news, Arihant Capital maintained a 'Buy' rating on the stock with a target price of ₹1,639. The brokerage suggests that the separation could help remove the conglomerate discount—a situation where a diversified company's value is lower than the sum of its parts—thereby highlighting the potential of each individual business.
Risks and Market Context
Investors should monitor specific business risks associated with the demerged entities. The spirits and chemicals segments are heavily dependent on raw materials like molasses, making them vulnerable to price volatility. Furthermore, the business is sensitive to regulatory and policy changes, such as shifts in excise duties and government mandates on ethanol blending, which can directly impact profitability.
In recent market activity, the stock experienced some volatility, with a decline of approximately 3% following a short winning streak. In an exchange filing on August 19, 2026, the company clarified that this movement in trading volume was driven by market forces and not due to any undisclosed company information or material events. Going forward, investors will likely track the operational independence of the new entities and whether the management can successfully execute the growth targets set for each individual company.